Myriad Genetics Inc (MYGN)
Days of sales outstanding (DSO)
| Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 6.75 | 6.49 | 6.52 | 6.35 | 6.23 | 5.81 | 6.65 | 8.03 | 7.57 | 8.26 | 9.27 | 7.12 | 6.22 | 5.85 | 6.73 | 8.84 | 7.14 | 6.58 | 6.75 | 6.06 | |
| DSO | days | 54.09 | 56.25 | 55.97 | 57.48 | 58.56 | 62.83 | 54.92 | 45.46 | 48.22 | 44.20 | 39.38 | 51.28 | 58.64 | 62.41 | 54.20 | 41.27 | 51.10 | 55.45 | 54.05 | 60.22 |
June 30, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.75
= 54.09
Days Sales Outstanding (DSO) is a key metric used to evaluate how long it takes a company to collect payments from its customers after making sales. A lower DSO indicates that the company is able to collect payments more quickly, which is generally seen as a positive sign of efficiency in managing accounts receivable.
Analyzing the DSO trend for Myriad Genetics Inc over the past few quarters, we observe fluctuations in the metric. In the most recent quarter, as of June 30, 2024, the DSO stood at 54.09 days, which is slightly lower compared to the previous quarter. This decrease suggests that the company may have improved its collections process or has been more effective in managing its accounts receivable.
Looking back over the past few quarters, the DSO has shown some variability. The highest DSO was recorded in the first quarter of 2023 at 62.83 days, indicating that the company took a longer time to collect payments during that period. On the other hand, the lowest DSO was reported in the first quarter of 2022 at 39.38 days, showcasing a significant improvement in the collection efficiency during that period.
Overall, while the DSO metric for Myriad Genetics Inc has exhibited fluctuations over the past quarters, it is essential for the company to monitor and manage this metric effectively to ensure timely collections and improved cash flow management. A sustained decrease in DSO over time could indicate efficient credit policies and stronger collections efforts, ultimately contributing to the company's financial health.
Peer comparison
Jun 30, 2024